Research Library

In a new brief, McClain Sampson, fellow in Maternal and Reproductive Health, and co-author Priscilla P. Kennedy summarize how the recent Texas Medicaid and CHIP extension will benefit families and explore the expected impacts of this extension.

It’s been two years since Winter Storm Uri swept across Texas, and the question of whether and how to end the isolation of the state’s grid remains. Nonresident scholar Julie Cohn offers a brief history of the standalone Texas grid to explore how the lessons of the past can inform the state’s electric power future.

As the energy transition continues, the viability of our power system is at stake. Nonresident scholar Julie A. Cohn explains the need to prepare for next-generation grid technology if we are to maintain a stable, economical and secure power system.

As the pandemic persisted across the state, did Texans living in cities have better access to Covid-19 vaccines than those in rural areas? How did race or age factor in? The authors assess the successes and shortfalls of Texas' vaccine distribution strategy, and how to do better next time.

In the transition to a renewable energy future, we must invest in a new transmission infrastructure – some crossing state borders – that connects intermittent power, traditional power and users, write Center for Energy Studies experts.

The high-growth, high-tech sector appears poised to dramatically grow. U.S. policy to support this sector could enhance and hasten its rise, or could destroy a new American dream.

To harness the power of the market for ideas, the federal government must fund the U.S. patent office to 21st century levels and enhance the rights of patent owners.

Ambassador Edward P. Djerejian, director of the Baker Institute, makes the case for a comprehensive North American strategy in which the U.S., Mexico and Canada act in concert to become the global superpower of the 21st century.

High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.

Ambassador Edward P. Djerejian, director of the Baker Institute, describes the key elements of a coherent strategy for defeating ISIS, incorporating both nearer-term strategies and long-term approaches.